Ask Warren

DongKook Pharmaceutical

086450 · KOSDAQ · ₩086450 · 동국제약

₩23,900▼ ₩150 (0.62%)End-of-day · Oct 29, 2026 · End-of-day prices.
Trade
Alert me
SellBuy
AnnualQuarterly

Income statement

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Revenue₩259B₩251B₩243B₩227B₩233B₩224B₩211B₩201B
Cost of sales₩115B₩110B₩110B₩102B₩109B₩104B₩97B₩89B
Gross profit₩144B₩141B₩133B₩124B₩124B₩120B₩114B₩111B
Operating income₩26B₩27B₩24B₩25B₩22B₩25B₩18B₩23B
Net income−₩9.1B₩26B₩52B₩4.3B₩91M₩18B₩41B₩8.4B
Net income to shareholders₩18B₩25B₩14B₩20B₩16B₩16B₩8.6B₩19B

Balance sheet

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Total assets₩1.1T₩1.1T₩1.1T₩1T₩998B₩983B₩953B₩921B
Current assets₩586B₩572B₩565B₩548B₩537B₩511B₩470B₩481B
Cash and equivalents₩74B₩59B₩56B₩50B₩67B₩67B₩50B₩33B
Total liabilities₩320B₩311B₩299B₩294B₩277B₩280B₩274B₩264B
Current liabilities₩287B₩278B₩267B₩263B₩239B₩240B₩233B₩225B
Borrowings₩956M₩1B₩1B₩997M₩908M₩845M₩848M₩75B
Total equity₩798B₩781B₩764B₩743B₩722B₩704B₩679B₩658B
Shareholders' equity₩697B₩679B₩664B₩645B₩626B₩610B₩603B₩578B

Cash flow

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Cash from operations₩32B₩23B₩24B₩11B₩23B₩11B₩31B₩14B
Capital spending₩19B₩13B₩14B₩10B₩14B₩4.6B₩5.3B₩6.7B
Free cash flow₩13B₩9.5B₩9.8B₩1B₩9.1B₩6.2B₩25B₩7.8B
Dividends paid——₩0₩0₩9.2B₩0₩0₩0

Consolidated where available. Amounts in won.

Also known as: DongKook Pharmaceutical / 동국제약 / 086450 / KRX:086450

Source: KRX statistical information